Top Markets
Coin of the day
Citius Oncology, Inc. Citius Oncology, Inc.

Citius Oncology, Inc.

CTOR
株式のランク #23802
Citius Oncology, Inc. concentrates on advancing innovative, targeted... Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.
株価
$0.7426
最終同期: 2026-08-21
時価総額
$69.05M
変化(1日)
-2.17%
変化(1年)
-57.57%
US
取引 Citius Oncology, Inc. (CTOR)

カテゴリー

Citius Oncology, Inc.(CTOR)の株価履歴
終値の最高値: $0.77 (2026-08-01)

終値の最安値: $11.37 (2024-07-01)
Citius Oncology, Inc. の株価履歴(2024 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -4.49%
2025 2.60%
2024 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$1.26K 76.64%
US
$270.77 51.02%
US
$265.40 26.02%
US
$493.69 44.66%
CH
$152.42 74.45%
US